JW Holdings Corporation (KRX:096760)
3,580.00
-120.00 (-3.24%)
At close: Jun 26, 2026
JW Holdings Revenue
JW Holdings had revenue of 243.22B KRW in the quarter ending March 31, 2026, with 1.54% growth. This brings the company's revenue in the last twelve months to 973.26B, up 7.63% year-over-year. In the year 2025, JW Holdings had annual revenue of 969.57B with 9.22% growth.
Revenue (ttm)
973.26B
Revenue Growth
+7.63%
P/S Ratio
0.25
Revenue / Employee
7.66B
Employees
127
Market Cap
247.70B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 969.57B | 81.86B | 9.22% |
| Dec 31, 2024 | 887.71B | -40.36B | -4.35% |
| Dec 31, 2023 | 928.07B | 63.54B | 7.35% |
| Dec 31, 2022 | 864.54B | 75.60B | 9.58% |
| Dec 31, 2021 | 788.94B | 7.42B | 0.95% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Huons Global | 845.30B |
| Dong-A ST | 830.27B |
| Suheung | 743.02B |
| Huons | 616.80B |
| Samjin Pharmaceuticals | 274.03B |
| Boditech Med | 165.84B |
| Korea United Pharm | 161.44B |
| Yungjin Pharm. | 158.79B |